Evidence map›Paper›PMID 28832429›Full record

Trial reportMenopause (New York, N.Y.)2018

Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS).

Dahima Cintron, Brian D Lahr, Kent R Bailey, Nanette Santoro, Robin Lloyd, JoAnn E Manson, Genevieve Neal-Perry, Lubna Pal, Hugh S Taylor, Whitney Wharton and 3 more

Open access · hybridAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Menopause (New York, N.Y.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Lessons from KEEPS: the Kronos Early Estrogen Prevention Study.Climacteric : the journal of the International Menopause Society · 2021
    Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Review
  11. Review
  12. Conceptualizing Sleep Satisfaction: A Rapid Review.Behavioral sciences (Basel, Switzerland) · 2024
    Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. The Effect ofJournal of clinical medicine · 2020
    Article
  18. Review
  19. Sex hormones and stroke: Beyond estrogens.Hormones and behavior · 2019
    Review
  20. A heartfelt message, estrogen replacement therapy: use it or lose it.American journal of physiology. Heart and circulatory physiology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 1 country.

Dahima CintronMayo Clinic Graduate School, Mayo Clinic Rochester, MN.
Brian D LahrDepartment of Health Sciences Research Division of Biomedical Statistics and Informatics, Mayo Clinic Rochester, MN.
Kent R BaileyDepartment of Health Sciences Research Division of Biomedical Statistics and Informatics, Mayo Clinic Rochester, MN.
Nanette SantoroDepartment of Obstetrics and Gynecology, University of Colorado at Denver, Aurora, CO.
Robin LloydDepartment of Internal Medicine, Mayo Clinic, Rochester, MN.
JoAnn E MansonDepartment of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Genevieve Neal-PerryDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA.
Lubna PalDepartment of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT.
Hugh S TaylorDepartment of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT.
Whitney WhartonDepartment of Neurology, Emory University, Atlanta, GA.
Fredrick NaftolinNYU Interdisciplinary Program in Menopause Medicine, New York University, New York, NY.
S Mitchell HarmanKronos Longevity Research Institute and the Phoenix Veterans Administration Health Care System, Phoenix, AZ.
Virginia M MillerDepartment of Surgery and Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN.
Mayo Clinic in Arizona · USMayo Clinic in Florida · USYale University · USEmory University · USHarvard University · USKronos Longevity Research Institute · USNew York University · USUniversity of Colorado Denver · USUniversity of Washington · US

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
MAYO CLINIC CENTER FOR TRANSLATIONAL SCIENCE ACTIVITIESUL1RR024150 · NCRR · MAYO CLINIC ROCHESTER · PI RIZZA, ROBERT A. · 2006 to 2011
$66.4M
YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Edward L Melanson · 1995 to 2026
$32.6M
CTSA: K12 COMPONENTKL2RR024130 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$19.3M
Clinical and Transtional Science InstituteKL2TR000143 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$11.9M
Sex-specific Risk for Vascular Dysfunction and Cognitive DeclineP50AG044170 · NIA · MAYO CLINIC ROCHESTER · PI MILLER, VIRGINIA M · 2012 to 2017
$6.1M
Mayo Clinic Center for Translational Science ActivitiesTL1TR000137 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$2.1M
Clinical and Transtional Science InstituteTL1RR024129 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$2.0M
Estrogen, Platelets, and ArtherosclerosisR01HL090639 · NHLBI · MAYO CLINIC ROCHESTER · PI BAILEY, KENT R, MILLER, VIRGINIA M · 2008 to 2012
$1.9M
NCATS NIH HHS KL2 TR000143NCATS NIH HHS TL1 TR000137NCATS NIH HHS UL1 TR001863NCRR NIH HHS KL2 RR024130NCRR NIH HHS TL1 RR024129NCRR NIH HHS UL1 RR024131NCRR NIH HHS UL1 RR024139NCRR NIH HHS UL1 RR024150NHLBI NIH HHS R01 HL090639NIA NIH HHS P50 AG044170NIDDK NIH HHS P30 DK048520
6 · The paper itself

Abstract

objectiveThis study determined whether two different formulations of hormone therapy (HT): oral conjugated equine estrogens (o-CEE; 0.45 mg/d, n = 209), transdermal 17β-estradiol (t-E2; 50 μg/d, n = 201) plus cyclic progesterone (Prometrium, 200 mg) or placebo (PBO, n = 243) affected sleep domains in participants of the Kronos Early Estrogen Prevention Study.

methodsParticipants completed the Pittsburgh Sleep Quality Index at baseline and during the intervention at 6, 18, 36, and 48 months. Global sleep quality and individual sleep domain scores were compared between treatments using analysis of covariance, and correlated with vasomotor symptom (VMS) scores using Spearman correlation coefficients.

resultsGlobal Pittsburgh Sleep Quality Index scores (mean 6.3; 24% with score >8) were similar across groups at baseline and were reduced (improved sleep quality) by both HT (average change -1.27 [o-CEE] and -1.32 [t-E2]) when compared with PBO (-0.60; P = 0.001 [o-CEE vs PBO] and P = 0.002 [t-E2 vs PBO]). Domain scores for sleep satisfaction and latency improved with both HT. The domain score for sleep disturbances improved more with t-E2 than o-CEE or PBO. Global sleep scores significantly correlated with VMS severity (rs = 0.170, P < 0.001 for hot flashes; rs = 0.177, P < 0.001 for night sweats). Change in scores for all domains except sleep latency and sleep efficiency correlated with change in severity of VMS.

conclusionsPoor sleep quality is common in recently menopausal women. Sleep quality improved with both HT formulations. The relationship of VMS with domains of sleep suggests that assessing severity of symptoms and domains of sleep may help direct therapy to improve sleep for postmenopausal women.

Indexed as

Administration, CutaneousAdministration, OralDouble-Blind MethodDrug Therapy, CombinationEstradiolEstrogens, Conjugated (USP)FemaleHot FlashesHumansMenopauseMiddle AgedProgesteroneSelf ReportSeverity of Illness IndexSleepSweatingEstradiolEstrogens, Conjugated (USP)Progesterone

Identifiers

PMID28832429
PMCPMC5771895
OpenAlexW2747429217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.